We have described previously a transcription-dependent induction of glycogen resynthesis by the vasoactive intestinal peptide (VIP) or noradrenaline (NA) in astrocytes, which is mediated by CAMP. Because it has been postulated that the CAMP-mediated regulation of energy balance in hepatocytes and adipocytes is channeled at least in pat-t through the CCAAT/enhancer binding protein (CYEBP) family of transcription factors, we tested the hypothesis that CYEBP isoforms could be expressed in mouse cortical astrocytes and that their level of expression could be regulated by VIP, by the VIPrelated neuropeptide pituitary adenylate cyclase-activating peptide (PACAP), or by NA. We report in this study that in these cells, CIEBPP and C/EBPG are induced by VIP, PACAP, or NA via the CAMP second-messenger pathway. Induction of C/EBPP and -6 mRNA by VIP occurs in the presence of a protein synthesis inhibitor. Thus, clebpp and clebp6 behave as CAMP-inducible immediate-early genes in astrocytes. Moreover, transfection of astrocytes with expression vectors selectively producing the transcriptionally active form of CIEBPP, termed liver-enriched transcriptional activator protein, or CIEBPG enhance the glycogen resynthesis elicited by NA, whereas an expression vector producing the transcriptionally inactive form of C/EBPP, termed liver-enriched transcriptional inhibitory protein, reduces this resynthesis. These results support the idea that CIEBPP and -6 regulate gene expression of energy metabolism-related enzymes in astrocytes.
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There is increasing evidence that neurotransmitters exert receptor-mediated effects in astrocytes (Barres, 1991; Murphy, 1993) . In particular, we have demonstrated pronounced shortand long-term effects of the vasoactive intestinal peptide (VIP) and the monoamine noradrenaline (NA) on astrocyte glycogen metabolism (Sorg and Magistretti, 1991, 1992; Magistretti et al., 1993) . Thus, activation of VIP or NA receptors leads within minutes to glycogenolysis, followed within a few hours by a massive glycogen resynthesis (Sorg and Magistretti, 1991, 1992) . Glycogen is the single largest energy reserve of the brain. It is localized predominantly in astrocytes, to such an extent that this cell type can be positively identified at the ultrastructural level by the presence of glycogen granules in the cytoplasm (Peters et al., 1991) . Glycogen turnover in the nervous system is very rapid and is under the control of multiple regulatory mechanisms (Magistretti, 1988 (Magistretti, , 1990 . Decreased synaptic activity that is achieved, for example, by anesthesia or slow-wave sleep markedly increases the glycogen content of the brain. Pathological conditions leading to neuronal loss, such as brain trauma, x-ray irradiation, or Alzheimer's disease, also cause a massive deposition of glycogen granules in the reactive astrocytes at the periphery of the lesioned areas [see Magistretti et al. (1993) and references therein]. The modulation of brain glycogen levels by VIP or NA led us to propose that the primary action of certain neurotransmitters is to regulate local-energy homeostasis within the CNS by acting on non-neuronal cells such as astrocytes (Magistretti, 1990 (Magistretti, , 1991 . The massive glycogen resynthesis elicited by VIP or NA in mouse cortical astrocytes is mediated by specific receptors coupled to the CAMP signal transduction cascade, and it is suppressed by cycloheximide or actinomycin D, which implies new protein synthesis (Sorg and Magistretti, 1992) .
In an attempt to characterize further this receptor-mediated translational-dependent event triggered by VIP or NA in a CAMPdependent manner (Sorg and Magistretti, 1992) , we focused our attention on a family of transcription factors called CCAAT/ enhancer-binding protein (C/EBP). Like the Fos/Jun and activating transcription factor/CAMP-responsive element binding protein (ATF/CREB) families, C/EBPs are characterized by a bipartite DNA-binding domain, composed of a basic region, contacting DNA, linked to a homo-or heterodimer-forming region called leucine zipper (for review, see Lamb and M&night, 1991; M&night, 1992) . The first member of this family, C/EBPa, was found at high levels in adipose, hepatic, and placental tissues and at lower levels in lung and small intestine (Birkenmeier et al., 1989) . Except for lung, each of these tissues can be considered to be part of the network of organs that facilitates the uptake, metabolism, and storage of physiological fuels. Therefore, it has been speculated that regulation of energy balance is channeled, at least in part, through C/EBPcv (McKnight et al., 198') ). The C/EBP family also includes C/EBP/3 (this is referred to in the literature also as NF-IM, IL-6-DBP, LAP, AGPIEBP, or CRP2), C/EBPS (also called CRP3, CELF, or NF-IL6/3), and CiEBPy (also known as Ig/EBP-I) (for review, see McKnight, 1992; ChcnKiang ct al., IYW) . Members of the C/EBP family can form homoor hcterodimers, all of which can bind to the same c&-regulatory elements. C/EBPa, -/3, and -6 arc involved in terminal diffcrcntiation of a variety of cells including adipocytcs, hepatocytcs, gut cpithelial cells, macrophages, and myelomonocytes (Friedman et al., lY89; Cao ct al., 1991; Natsuka et al., lY92; Scott et al., lYY2; Chandrasekaran and Gordon, 1003; Yeh et al., 199.5) . Furthermore, C/EBPp and -6 activate various genes involved in acutcphase, inflammatory, and immune rcsponscs (Akira and Kishimote, 1992; Chen-Kiang et al., 1903) [: see also Tanaka et al. ( 1995) and references therein]. Thus, C/EBPs appear to be pleiotropic transactivators involved in tissue-specific metabolic gene transcription, in signal transduction activated by several cytokines, and in cell ditfcrcntiation.
Because some C/EBP isoforms stimulate the expression of gcncs encoding for enzymes involved in cnergymetabolism regulation and because C/EBPp and -6 have been shown to bc implicated in CAMP responsiveness (Kagcyama et al., IYYI; Mctz and Ziff, 1991; Park ct al., lYY3 ; Vallcjo ct al., lYY3), we tested the hypothesis that members of the CiEBP family are cxprcssed in astrocytes and that their level of expression is regulated by VIP, by the VIP-related neuropeptidc pituitary adcnylate cyclnsc-activating polypeptide (PACAP), or by NA.
In this report, WC demonstrate that in mouse cortical astrocytes VIP, PACAP and NA increase C/EBPp and -6 isoforms at the mRNA and protein lcvcls via a CAMP-dependent mechanism. Induction of C/EBP/3 and -6 mRNA by VIP is rapid and occurs in the presence of a protein synthesis inhibitor. c/el~j~~ and ciebp6, therefore. can be considered to bc CAMP-inducible immediateearly genes in mouse astrocytcs. Moreover, overexpression of C/EBPS or liver-enriched transcriptional activator protein (LAP), the transcriptionally active form of CIEBPP, by transient transfection of astrocytes with expression vectors containing their cDNA sequence, showed that thcsc transcription factors can incrcasc NA-mediated glycogen resynthesis. This suggests that C/EBPp and -6 are primary target genes of the signal transduction pathway triggered by VIP, PACAP27, or NA, which regulate glycogcn metabolism in the brain. Four hours later, NA was added to the medium to a final concentration of 10-' M, and cultures were maintained for 6 hr in the incubator.
MATERIALS
The reaction then was stopped by washing the cells three times with ice-cold PBS and by adding either 1.5 ml of 30 mM HCI for the glycogen assay or 50 ~1 of lysis buffer for Western immunoblot analysis.
For the glycogen assay, the cells were sonicated and the suspension was used to measure glycogen as described previously by Sorg and Magistretti (1992 The first aliquot gave the sum of glucose and glucose-h-phosphate, and the second gave the sum of glycogen, glucose, and glucose-h-phosphate; the amount of glycogen then was determined by the difference between the first two aliquots. The third aliquot was used to measure the protein content following the method of Bradford (1976) . We should note that in this report, 1 mole of glycogen corresponds to I mole of glycosyl units originating from glycogen. ATP, NADP, and the enzymes were purchased from Boehringer Mannheim. Statistical analyses were performed by ANOVA followed by Dunnett's test.
RESULTS
C/EBPp and -6 are induced by VIP in mouse cortical astrocytes
To determine whether members of the C/EBP family were induced or modulated after exposure of mouse cortical astrocytes to VIP, we performed Western immunoblot analyses with antibodies against the well characterized CIEBP~U, -/3, and -6 isoforms. Although C/EBPa was not detected, either by Western immunoblot or by Northern blot (data not shown), we observed that the C/EBPp and -6 isoforms were induced in a time-dependent manner by lo-' M VIP (Fig. 1A) . The antibody against C/EBPP recognized two proteins with M, of 39 and 36 kDa; these proteins, which have been shown to be synthesized from C/EBPp mRNA, correspond to translation products initiated at the first and second in-frame AUGs of the CIEBPP mRNA; the initiation at the first in-frame AUG is less efficient than at the second in-frame AUG (Descombes and Schibler, 1991 ). An increase in C/EBPP protein levels occurred 2 hr after VIP exposure, reached a peak level between 4 and 8 hr, and began to decrease 12 hr after the onset of treatment (Fig. L4) . Analysis of the time course of the induction of CIEBPG showed that, unlike CIEBPP, an increase in C/EBPS can be observed only 30 min after VIP exposure. C/EBPS reached a maximal level after 4 hr, and unlike CIEBPP, still remained stable at high levels of expression 24 hr after exposure to VIP. Because basal levels of CIEBPS were higher than those of C/EBPp and appeared to be sensitive to conditions of stress, such as medium renewal, we performed a control manipulation (i.e., same processing of the astrocytes without adding VIP) at each point of the time course. As indicated in Figure lB , VIP induced C/EBP/3 and -6 expression in a concentration-dependent manner, between lo-' and 10ph M. To confirm that the induction of C/EBPP and -6 proteins actually was caused by an increase in their mRNA, we analyzed by Northern blotting total RNA extracted from astrocytes exposed to IO-' M VIP for various periods of time (Fig. 24) . These results confirmed the induction of C/EBP/3 and -6 at the mRNA level. As expected, the variations in mRNA levels preceded the variations in C/EBPp or -6 protein levels. C/EBPp mRNA levels increased already 30 min after VIP exposure, reached a peak between 2 and 4 hr, and decreased 8 hr after the onset of treatment. C/EBPS mRNA levels increased gradually over time, stabilized at 4 hr, and remained maximally induced until at least 24 hr after addition of VIP (Fig. 248) . The increase in C/EBPS mRNA 1.5 and 30 min after VIP exposure was weaker than the increase in CYEBPS protein at 30 min. This apparent inconsistency might be explained by the fact that a single mRNA molecule can be translated several times, thus providing an amplified signal at the protein level. Taken together, these results demonstrate that in mouse cortical astrocytes, VIP induces C/EBPp and -6 at the mRNA and protein levels in a time-and concentration-dependent manner.
C/EBPP and -6 are induced by VIP as immediate-early genes Because C/EBPp and -6 arc transcription factors induced relatively rapidly by VIP, we wondered whether these two CIEBP isoforms were immediate-early response genes activated directly by constitutively expressed transcription
factors. An immediateearly gene is defined as a gene that can be induced without & nova protein synthesis and, therefore, is not blocked by inhibitors of protein synthesis (for review, see Herschman, 1991). We therefore exposed mouse cortical astrocytes to the protein synthesis inhibitor anisomycin at 20 PM for 30 min before VIP exposure, extracting total RNA 2 hr later (Fig. 3) . In these conditions, protein synthesis was abolished almost completely (see legend of Fig. 3) . Results indicated that C/EBPp and -6 mRNA production still was enhanced by VIP in the presence of anisomycin, suggesting that VIP induces ciebpp and c/ebpS gene transcription via a protein synthesis-independent mechanism. Treatment of astrocytes with anisomycin alone produced an induction of the C/EBPp and -6 mRNAs (Fig. 3) . This phenomenon, called superinduction, has been described previously and is thought to reflect the loss of labile transcriptional repressors or mRNA-degrading enzymes and, in general, is believed to be a direct consequence of the inhibition of protein synthesis. Independent of its ability to block translation, anisomycin also causes side effects, by intrinsically initiating intracellular signals and immediate-early gene induction (Cano et al., 1994) . Regardless of the process that caused the superinduction of CIEBPS mRNA, we concluded from these experiments that the induction of c/ebp/? and clebpd gene transcription did not require new protein synthesis and, therefore, defined clebpj3 and c/ebpS as immediate-early genes in mouse cortical astrocytes.
C/EBPP and -6 are localized in the nucleus of GFAP-positive cells
The primary cultures of astrocytes used in this study contain >90% of cells immunoreactive for the astrocytic marker GFAP. The remaining 10% is composed of progenitor cells for oligodendrocytes, astrocytes, and microglia. It was necessary, therefore, to confirm that C/EBPP and -6 indeed were expressed by GFAP-positive cells. To do this, we performed double-immunofluorescence labeling of GFAP and C/EBP/l or GFAP and C/EBPS (Fig. 4) . These results clearly showed that C/EBP/3 and -6 are expressed and localized in the nucleus of mouse cortical astrocytes exposed to VIP. The use of neutralizing peptides corresponding to the C-terminal part of C/EBPP or -S demonstrated the specificity of the antibodies against the C/EBP isoforms. In rat pheochromocytoma (PC)-12 cells, a translocation of CIEBPP from the cytoplasm to the nucleus after CAMP stimulation was described by Metz and Ziff (1991) . Because the basal levels of C/EBP/3 were barely detectable, we did not observe such a translocation in mouse cortical astrocytes after exposure to VIP. The basal levels of C/EBPS were higher, with the protein specifically immunolocalized in the nucleus and not detected in the cytoplasm.
PACAP induces C/EBPp and -6 in mouse cortical astrocytes A major action of VIP in the cerebral cortex is the stimulation of CAMP formation (Magistretti and Schorderet, 1984) ; therefore, we addressed the question of whether the VIP-related neuropeptide PACAP also induced C/EBPP or -6, because PACAP stimulates CAMP formation more potently than VIP in rat primary astrocytes (Hashimoto et al., 1993) . Two forms of PACAP, PACAP and PACAP27, have been identified and demonstrated to be equally potent in stimulating the adenylate cyclase (for review, see Arimura, 1992). We applied PACAP to mouse cortical astrocytes and found that it induced CIEBPP and -6 expression in a concentration-dependent manner between lo-' and lo-' M (Fig. 5B) . PACAP27, therefore, is lo-fold more potent than VIP in stimulating C/EBPP and -6 expression. However, some differences in the time course of C/EBPS induction by PACAP were observed compared with the time course of C/EBPS induction by VIP. Thus, C/EBPS protein levels increased only 4 hr after PACAP exposure and returned to the basal level 24 hr after PACAP exposure (Fig. 54) . Therefore, unlike VIP, PACAP induced C/EBP/? and -6 with a similar time course.
NA induces CYEBPP and -6 in mouse cortical astrocytes Given the effects of VIP or the monoamine neurotransmitter NA on the energy metabolism of mouse astrocytes, as well as the capacity of NA to stimulate adenylate cyclase, we tested whether NA could induce C/EBPP or -6 isoforms. When NA was applied to mouse cortical astrocytes, we observed by Western immunoblot analysis the most rapid and persistent induction of C/EBPp and -6 protein levels among the three neurotransmitters tested (Fig. 6,4) . These levels still remained high 24 hr after NA exposure, although C/EBPP levels were lower than the maximal induction observed at 4 hr. Furthermore, NA induced CIEBPP and -6 in a concentration-dependent manner, with an effect already apparent at lo-' M (Fig. 6B) . This induction could be mimicked by the /3-adrenergic receptor agonist isoproterenol, but not by the (Y,-agonist methoxamine (Fig. 6C) . Moreover, the NA-mediated C/EBPP and -6 induction was decreased by the /31-adrenergic receptor antagonist atenolol, but not by the a,-antagonist prazosin. Taken together, these pharmacological analyses strongly suggest that NA induces C/EBPP and -6 via receptors of the p-subtype that are coupled to adenylate cyclase (for review, see Summers and McMartin, 1993) .
8-(CBromo)-CAMP and forskolin induce C/EBP/3 and -6 in mouse cortical astrocytes The foregoing results provided a strong indication that VIP, PACAP27, and NA likely induce CIEBPP and -6 by increasing intracellular CAMP levels in mouse cortical astrocytes. This was confirmed further by the observation that the CAMP analog 8-(4-bromo)-CAMP [8-(4Br)-CAMP] and the direct adenylate cyclase activator forskolin also induced CIEBPP and -6 (Fig. 7) . The kinetics of the induction of C/EBPP and -6 by 8-(4Br)-CAMP or forskolin was similar to that observed with VIP, PACAP27, or NA. Thus, clebpp and clebp6 can be considered to be CAMPresponsive immediate-early genes in mouse cortical astrocytes.
PACAP and NA induce CIEBPP and -6 mRNA in mouse cortical astrocytes To confirm that the induction of C/EBPP and -6 by PACAP or NA was caused by an increase in their mRNA, we analyzed by Northern blotting total RNA extracted from astrocytes exposed for 2 hr to these two neurotransmitters. As shown in Figure 8 , lo-' M PACAP or lo-' M NA induces C/EBPP and -6 mRNAs to a similar extent as IO-' M VIP.
Involvement of CYEBPS and LAP in glycogen resynthesis
Because we demonstrated that the /3 and S isoforms of the C/EBP family of transcription factors were induced rapidly by VIP, PACAP27, or NA in mouse cultured cortical astrocytes, we considered the possibility that these factors mediate the CAMP-and protein synthesis-dependent resynthesis of glycogen elicited by VIP or NA in these cells (Sorg and Magistretti, 1992) . To test this hypothesis, we first attempted to overexpress C/EBPP or -6 by transfecting astrocytes with expression vectors containing their cDNA. We monitored the expression of the C/EBP isoforms by Western immunoblotting. Although C/EBPS was overexpressed efficiently, C/EBPP was expressed only poorly (data not shown). The failure to overexpress C/EBPP likely was attributable to an inefficient initiation of translation, because the C/J3BP/3 mRNA can be translated from three in-frame AUGs to yield three proteins called LAP*, LAP, and LIP (Descombes and Schibler, 1991) . Therefore, we decided to construct the MSV-LAP and MSV-LIP expression vectors as described by Yeh et al. (1995) . The introduction of an optimal Kozak consensus sequence upstream from the second or third in-frame AUG allowed the selective overexpression of the transcriptionally active form of C/EBPP, termed LAP, or the transcriptionally inactive form of CIEBPP, termed LIP, respectively. Although LAP and C/EBPS were expressed at high levels after the transfection of astrocytes, glycogen levels were not enhanced significantly (data not shown). Of interest, however, overexpression of LIP reduced glycogen levels significantly, which were 18.2 2 0.9 nmol of glycogen/mg of protein for the astrocytes transfected with MSV-no insert and 11.2 t 2.8 nmol of glycogen/mg of protein for the astrocytes transfected with MSV-LIP, which suggests that glycogen synthesis was inhibited by the LIP-mediated inhibition of C/EBP isoforms. One possible explanation for the inefficiency of LAP and C/EBPG to increase glycogen levels is that a physiological response implying new protein synthesis, such as the resynthesis of glycogen in astrocytes, rarely is controlled by a single transcription factor. Tissue-specific gene transcription depends on a combination of &acting elements, which are recognized by several transcription factors that, by binding simultaneously to the gene promoter, favor the formation of the transcription initiation complex and the subsequent RNA synthesis by the RNA polymerase II. Therefore, if resynthesis of glycogen elicited by VIP or NA requires the induction of several transcription factors, then the overexpression of only one of these transcription factors would not be sufficient to increase glycogen levels. Because of this, we decided to transfect astrocytes with the expression vectors and then, after a period sufficient to overexpress LAP, LIP, or C/EBPG, expose the transfected astrocytes to NA. The rationale for this protocol was that because glycogen resynthesis is a transcriptionally regulated CAMPdependent phenomenon (Sorg and Magistretti, 1992) , increases in CAMP levels triggered by NA could induce or activate other di d not cause a loss of immunoreactivity in the nucleus of GFAP-positive cells. E, Fluorescein staining of C/EBPS. F, Rhodamine staining of the astrocytic marker GFAP and fluorescein staining of C/EBPG within the field shown in E. C/EBPS is localized in the nucleus of the GFAP-positive cells. G, Control of the anti-C/EBPG antibody specificity. Preincubation of the antibody against C/EBPG with the peptide corresponding to CiEBPp did not cause a loss of immunoreactivity in the nucleus of GFAP-positive cells. H, Control for nonspecific fluorescein labeling with the antibody against C/EBPG. Neutralization of anti-C/EBPG antibody with the peptide against which it has been raised caused a total loss of nuclear staining. Scale bar, 50 pm. transcription factors that could synergize with the overexpressed LAP or C/EBPG to stimulate glycogen resynthesis maximally.
Moreover, we decided to expose transfected astrocytes to NA for 6 hr to measure glycogen levels when the rate of resynthesis is high (Sorg and Magistretti, 1992) . A set of cultures was used to determine glycogen levels (Fig. 9A) , and another set was used to monitor the overexpression of LAP, LIP, or C/EBPG by Western immunoblot analysis (Fig. 9B) . Although the observed increase over basal glycogen levels was not proportional to the LAP or C/EBPS level, the overexpression of LAP or C/EBPS significantly and reproducibly increased the NA-induced glycogen resynthesis of the transfected astrocytes compared with astrocytes transfected with the control vector. Moreover, the overexpression of LIP reduced the NA-induced glycogen resynthesis. These results suggest that C/EBPG and the transcriptionally active form of CiEBPp play a role in the glycogen resynthesis triggered by NA. Cultures of cortical astrocytes were transfected transiently using the cationic lipid DOTAP with the MSV-no insert control plasmid (no insert) or with MSV-LAP, MSV-LIP, or MSV-CEBPS expression vectors. Three days after transfection, astrocytes were incubated in the presence of IO-' M NA, and glycogen levels were assayed 6 hr later. A, Results are expressed as the percent glycogen level in astrocytes transfected with the MSV-no insert control plasmid, which was 347.6 i: 9.7 nmol of glycogemmg of protein. Results are expressed as mean + SEM of six separate determinations from two experiments, repeated twice with similar results. Asterisks indicate significant difference from MSV-no insert by ANOVA followed by Dunnett's test (p < 0.01). The error bar at the leff represents SEM of MSV-no insert. B, Western blot monitoring the expression of LAP, LIP, or UEBPS in astrocytes transiently transfected with MSV-no insert, MSV-LAP, MSV-LIP, or MSV-UEBPS. Parallel astrocyte cultures treated as in A were analyzed by Western immunoblot to detect C/EBPP (LAP or LIP) and CIEBPG isoforms. Equal amounts of total protein extracts (50 pg) were separated by 12% SDS-PAGE. The bands identified as LAP' and UP correspond to the proteins of 39 and 36 kDa, respectively, designated C/EBPp in the other figures. CIEBPG was detected with an affinity-purified rabbit polyclonal antibody (1:500, Santa Cruz Biotechnology). Note that the chemiluminescent blots were exposed for a brief period to avoid saturation of the signal for the overexpressed LAP, LIP, and CiEBPS. Consequently, the signal of C/EBPP and -6 was reduced considerably in the other lanes. (Cao et al., 1991) whereas in situ hybridization experiments localized C/EBPa mRNA in adult mouse brain, where it was concentrated primarily in the hippocampus, cerebellar Purkinje cells, and layers II and III of the cortex (Kuo et al., 1990) . Such analysis has not been performed for C/EBP/3 or -6 mRNAs. However, the human homolog of C/EBPp has been identified in a glioblastoma cell line (Akira et al., 1990) . Directly relevant to the present study is the report by Kageyama et al. (1991) who, while attempting to clone rat brain cDNAs on the basis of their ability to bind the CAMP-responsive element (CRE) of the substance P and K precursor gene promoter, cloned in fact the rat homolog of CIEBPS, which they termed C/EBP-like factor (or CELF). In this latter study, C/EBPS mRNA could be detected in rat whole brain by Northern blot analysis performed with polyA+ RNA. C/EBPp is regulated by the CAMP second-messenger pathway also in the rat PC12 cell line (Metz and Ziff, 1991) . The activity, as well as the expression, of C/EBP family members is also regulated by CAMP. Thus, the CAMP-stimulated phosphorylation of C/EBPp is associated with its translocation to the nucleus, in which it can induce transcription of the cellular protooncogenc c-fos via interactions with the c-fos serum response element. A c/&y gene was shown recently to be activated by stimulation of serotonin receptors, which are coupled to the CAMP pathway in sensory neurons of the marine snail Aplysia (Alberini et al., 1994) (for review, see Stevens and Verma, 1994) . Serotonin, a neurotransmitter released from neurons involved in a simple form of learning called sensitization, rapidly induced Aplysia C/EBP (ApC/EBP), even in the presence of protein synthesis inhibitors. Moreover, ApC/EBP plays a crucial role in the consolidation of stable, long-term synaptic plasticity in Aplysia. The induction of C/EBPp and -6 by VIP, PACAP27, or NA in mouse cortical astrocytes reported in this study shares a number of similarities with the induction of ApC/EBP by serotonin in Aplysio sensory neurons. Thus, ApCiEBP mRNA is induced by 8-(4Br)-CAMP or forskolin, and its induction by serotonin is not blocked by anisomycin (Alberini et al., 1994) . It is of interest that regulatory mechanisms of C/EBP family members have been conserved during evolution from neurons in a simple organism like Aplysiu to glial cells in a mammalian brain.
In this study, we also show that the overexpression of CIEBPS and LAP significantly increases the NA-induced glycogen accumulation of transfccted astrocytes. However, the increase in glycogen is not proportional to the increase in C/EBPS or LAP. This is not surprising, because it is well known that transient transfection of expression vectors causes a small percentage of productively transfected cells. For instance, the transfection of hepatoma (HepG2) cells with the expression vector MSV-C/EBPa leads to the appearance of C/EBPa overexpression in only 1% of the cells (Friedman et al., 1989) . This observation also applies to the mouse primary cultures of astrocytes transfected with MSV-C/ EBPS or MSV-LAP, because we observed by immunocytochemistry only a small percentage (3-50/o) of cells expressing high levels of CIEBPS or LAP (data not shown). Therefore, the increase in glycogen levels in productively transfected astrocytes would be reflected only marginally in total glycogen levels. Moreover, C/EBPS and LAP likely are not the only limiting transcription factors of glycogen synthesis, and their overproduction cannot increase glycogen levels proportionally if the other limiting factors are not expressed to the same extent as C/EBPS or LAP. One such transcription factor could be activator protein-l, because the c$is gene is induced by VIP or NA in cultured astrocytes (Arcnander et al., 1989; Martin et al., 1992) . In view of these considerations, the significant increase in glycogen levels after transfection of astrocytes with the CIEBPS or LAP expression vector strongly supports an involvement of C/EBPp and -6 in the transcriptionally regulated CAMP-dependent resynthesis of glycogen evoked by VIP and NA.
Which could be the target genes of C/EBP isoforms, the induction of which would lead to an increase in glycogen levels? A number of enzymes are potential candidates for such regulation. For example, transcription of the glycogen synthase gene might be enhanced by VIP or NA via the activation of c/&l>/3 or c/e/@ genes. The glycogen synthase cDNA from mouse astrocytes has been cloned recently in our laboratory, and the level of expression of its mRNA indeed is increased by VIP or NA (Pellegri ct al., in press). The promoter of the glycogen synthase gene has not been studied and, therefore, it is not known whether it contains CIEBPbinding sites. However, very recently an impaired-energy homeostasis in C/EBPa knock-out mice has been reported (Wang et al., 1995) . Of interest, mice homozygous for the targeted deletion of the clebpa gene did not store hepatic glycogen and died from hypoglycemia within 8 hr after birth. In these mutant mice, the amounts of glycogen synthase mRNA were 30-50%' of normal, which strongly suggests that this gene is regulated by C/EBP isoforms. Glycogen synthesis could be controlled also by the availability of glucose-6-phosphate, which is regulated by the sequential activity of the glucose transporter and hexokinase. There are several glucose transporters and several isoforms of hexokinase. As for glycogen synthase, the promoter of the brain isotypes of these proteins has not been studied. However, CiEBP might play a role in the transcriptional regulation of these genes, because C/EBP-binding sites were observed in the promoter of the insulin-responsive glucose transporter gent (Kaestner et al., 1990) whereas in the liver the dynamics of the pattern of expression of C/EBPa mRNA were virtually identical to that of the hexokinase IV (glucokinase) mRNA (Moorman et al., 1991) . It is conceivable, therefore, that VIP or NA, by inducing C/EBPp and -6 in mouse cortical astrocytes, increases the transcription of the glucose transporter and/or the hexokinase genes, leading to a stimulation of glycogen synthesis.
In addition to the involvement of C/EBP isoforms in the glycogen resynthesis elicited by VIP or NA, this study provides evidence that neurotransmitters can influence gene transcription in astrocytes, therefore demonstrating yet another level of regulation in neuron-glia interactions. Moreover, as noted in the introductory remarks, the C/EBP transcription factor family plays several well documented roles in peripheral tissue, which provide useful clues to define the functions of these transcription factors in the CNS.
